This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Vivian Xie
17 Apr 2025

Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery

Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery. 

As pharmaceutical companies shift toward more complex and personalised treatments, packaging innovation is becoming a critical factor in drug development. With biologics and targeted therapies gaining prominence, the need for packaging that accommodates unique delivery, storage, and patient usability requirements is accelerating. 

Biologics – complex formulations that often require refrigeration and device-based delivery – are driving demand for cold chain-compatible, patient-friendly packaging solutions. Asmita Khanolkar of SMC Ltd. emphasizes the importance of tailored strategies for biologics, especially given the rise of self-administration and smaller patient populations for personalized treatments. Unlike mass-market drugs of the past, today’s therapies must be designed with precision and flexibility in mind. 

The popularity of GLP-1 agonists, which are used to treat diabetes and obesity, underscores the growing market for high-value injectables. With forecasts estimating these drugs could generate over $100 billion by 2030, pharmaceutical companies are focusing more on delivery systems like autoinjectors and wearable devices. These solutions enhance ease of use and support home-based care – an increasingly important model as the global population ages. 

Beyond biologics, packaging for oral formulations is evolving as well. Modified-release tablets, high-potency APIs, and orphan drugs are spurring demand for protective blister packs and containment solutions that ensure safety and compliance. 

Digitisation is also transforming pharmaceutical packaging. AI and machine learning are being used to improve patient adherence through smart packaging, such as connected pill bottles and electronic dose tracking systems. These technologies can also enhance supply chain operations, personalize packaging design, and support sustainability goals by reducing waste and optimising materials. 

Looking ahead, investments in advanced formulations – like long-acting injectables, microneedles, and implantable devices – are expected to grow. These innovations demand precise fill-finish technologies and scalable packaging processes. As the pharmaceutical landscape becomes more patient-centric and data-driven, packaging will play a central role in delivering both therapeutic effectiveness and improved user experiences. 

In this evolving market, pharmaceutical packaging is no longer an afterthought – it’s a strategic asset that bridges therapy, technology, and patient needs. 

Discover the full Pharmaceutical Packaging Market Prospects Trend Report here.

Related News